SBI Securities’s Creative Medical Technology CELZ Stock Holding History

SBI Securities’s Portfolio CELZ Stock Details CELZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62	Buy	43 +42	+4,200%	+$91	﹤0.01%	3622
2026 Q1	$2	Hold	1	–	–	﹤0.01%	3957
2025 Q4	$2	Hold	1	–	–	﹤0.01%	3968
2025 Q3	$3	Buy	+1	New	+$3	﹤0.01%	4126

Other funds holding CELZ

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

SBI Securities's CELZ Position: Q2 2026 in Review

SBI Securities increased its Creative Medical Technology (CELZ) stake by 4,200% in Q2 2026, buying an estimated $91 and bringing the position to 43 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

SBI Securities first reported a position in CELZ in Q3 2025 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

SBI Securities held 43 shares of Creative Medical Technology worth $62 as of Q2 2026.
SBI Securities bought 42 Creative Medical Technology shares in Q2 2026, an estimated $91.
Creative Medical Technology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3622 holding.
SBI Securities first reported a position in Creative Medical Technology in Q3 2025 and has held it in 4 quarters since.
2 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.